2-[[2-[2-(2-fluoroethoxy)-4-pyridinyl]-5-propyl-1,3-thiazol-4-yl]methylsulfanyl]pyrimidine-4,6-diamine
C18H21FN6OS2 — CID 126699918
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[2-[2-(2-fluoroethoxy)-4-pyridinyl]-5-propyl-1,3-thiazol-4-yl]methylsulfanyl]pyrimidine-4,6-diamine
2-[[2-[2-(2-fluoroethoxy)-4-pyridinyl]-5-propyl-1,3-thiazol-4-yl]methylsulfanyl]pyrimidine-4,6-diamine (PubChem CID 126699918) has the molecular formula C18H21FN6OS2 and a molecular weight of 420.54 g/mol. Its IUPAC name is 2-[[2-[2-(2-fluoroethoxy)-4-pyridinyl]-5-propyl-1,3-thiazol-4-yl]methylsulfanyl]pyrimidine-4,6-diamine.
Molecular Properties
| Compound Name | 2-[[2-[2-(2-fluoroethoxy)-4-pyridinyl]-5-propyl-1,3-thiazol-4-yl]methylsulfanyl]pyrimidine-4,6-diamine |
|---|---|
| PubChem CID | 126699918 |
| Molecular Formula | C18H21FN6OS2 |
| Molecular Weight | 420.54 g/mol |
| Exact Mass | 420.12 |
| IUPAC Name | 2-[[2-[2-(2-fluoroethoxy)-4-pyridinyl]-5-propyl-1,3-thiazol-4-yl]methylsulfanyl]pyrimidine-4,6-diamine |
| SMILES | CCCc1sc(-c2ccnc(OCCF)c2)nc1CSc1nc(N)cc(N)n1 |
| InChI | InChI=1S/C18H21FN6OS2/c1-2-3-13-12(10-27-18-24-14(20)9-15(21)25-18)23-17(28-13)11-4-6-22-16(8-11)26-7-5-19/h4,6,8-9H,2-3,5,7,10H2,1H3,(H4,20,21,24,25) |
| InChIKey | AALBHRUBIFNNOQ-UHFFFAOYSA-N |
| XLogP | 3.75 |
| TPSA | 112.83 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 420.54 |
| LogP ≤ 5 | 3.75 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126699918 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.